Dolby Laboratories (NYSE:DLB – Get Free Report) CMO Todd Pendleton sold 11,876 shares of Dolby Laboratories stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $54.55, for a total transaction of $647,835.80. Following the sale, the chief marketing officer owned 41,480 shares of the company’s stock, valued at approximately $2,262,734. This trade represents a 22.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Dolby Laboratories Price Performance
Shares of NYSE DLB opened at $55.67 on Thursday. The company has a market cap of $5.27 billion, a PE ratio of 22.00 and a beta of 0.86. Dolby Laboratories has a 12 month low of $52.45 and a 12 month high of $77.00. The company has a 50-day simple moving average of $59.68 and a 200-day simple moving average of $63.14.
Dolby Laboratories (NYSE:DLB – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, topping analysts’ consensus estimates of $1.31 by $0.06. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The business had revenue of $395.63 million during the quarter, compared to the consensus estimate of $385.80 million. During the same period in the previous year, the firm posted $1.34 earnings per share. The company’s quarterly revenue was up 7.0% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, analysts anticipate that Dolby Laboratories will post 3.2 EPS for the current year.
Dolby Laboratories Announces Dividend
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the company. Boothbay Fund Management LLC lifted its position in shares of Dolby Laboratories by 4.1% during the second quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock worth $299,000 after purchasing an additional 157 shares in the last quarter. Covestor Ltd lifted its position in shares of Dolby Laboratories by 6.0% during the fourth quarter. Covestor Ltd now owns 3,088 shares of the electronics maker’s stock worth $198,000 after purchasing an additional 175 shares in the last quarter. Fifth Third Bancorp lifted its position in shares of Dolby Laboratories by 34.7% during the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock worth $48,000 after purchasing an additional 192 shares in the last quarter. State of Michigan Retirement System lifted its position in shares of Dolby Laboratories by 1.4% during the first quarter. State of Michigan Retirement System now owns 14,700 shares of the electronics maker’s stock worth $883,000 after purchasing an additional 200 shares in the last quarter. Finally, Gabelli Funds LLC lifted its position in shares of Dolby Laboratories by 0.4% during the third quarter. Gabelli Funds LLC now owns 49,143 shares of the electronics maker’s stock worth $3,556,000 after purchasing an additional 202 shares in the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.
Trending Headlines about Dolby Laboratories
Here are the key news stories impacting Dolby Laboratories this week:
- Positive Sentiment: Zacks Research raised several forward earnings forecasts for Dolby Laboratories, including FY2026, FY2027, FY2028, and multiple quarterly periods, which can support the case for stronger future profitability. Analyst estimate updates
- Positive Sentiment: The firm also lifted its Q1 2027, Q2 2027, Q4 2027, Q1 2028, and Q2 2028 EPS estimates, reinforcing expectations for earnings growth over the next few years. Analyst estimate updates
- Neutral Sentiment: Zacks Research lowered its Q3 2026 EPS estimate, showing that not all near-term expectations are improving and leaving the outlook mixed. Analyst estimate updates
- Negative Sentiment: Dolby CMO Todd Pendleton sold 11,876 shares at an average price of $54.55, a transaction that reduced his holdings by 22.26%, which may weigh on investor sentiment. SEC filing
Analyst Upgrades and Downgrades
A number of research firms recently issued reports on DLB. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Friday, March 27th. Wall Street Zen cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, January 31st. Barrington Research reaffirmed an “outperform” rating and set a $90.00 price target on shares of Dolby Laboratories in a research report on Monday, April 27th. Finally, Rosenblatt Securities reaffirmed a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a research report on Friday, January 30th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, Dolby Laboratories presently has an average rating of “Moderate Buy” and a consensus price target of $90.75.
Get Our Latest Stock Report on DLB
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Further Reading
- Five stocks we like better than Dolby Laboratories
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
